Organic Letters
Letter
catalytic hydrogenation (Scheme 1). Through judicious selection
of conditions for removal of the PMB group, it is possible to
prepare peptides with the piperazic acid moiety in the desired
oxidation state.
To demonstrate this novel IMCR’s utility, we used it to
efficiently synthesize the bicyclic core structure of Pralnacasan
(Figure 1). This interleukin 1β-converting enzyme inhibitor was
rationally designed and synthesized by Vertex Pharmaceuticals
for use as a potential anti-inflammatory drug.4 The first and key
transformation in the synthetic route was condensation of N-
Cbz-Glu(OMe)-OH, PMB-THP, and tert-butyl isocyanide
(Scheme 2). Following removal of the IMCR product’s PMB
REFERENCES
■
(1) (a) Grunewald, J.; Marahiel, M. A. Handbook of Biologically Active
̈
Peptides 2013, 138. (b) Caboche, S.; Leclere, V.; Pupin, M.; Kucherov,
G.; Jacques, P. J. Bacteriol. 2010, 192, 5143.
(2) For a recent review of piperazic acid natural products and their
syntheses, see: Oelke, A. J.; France, D. J.; Hofmann, T.; Wuitschik, G.;
Ley, S. V. Nat. Prod. Rep. 2011, 28, 1445.
(3) Natoff, I. L.; Mixon, J. S.; Francis, R. J.; Klevans, L. R.; Brewster, M.;
Budd, J.; Patel, A. T.; Wenger, J.; Worth, E. J. Cardiovasc. Pharmacol.
1985, 7, 569.
(4) Rudolphi, K.; Gerwin, N.; Verzijl, N.; Van der Kraan, P.; Van den
Berg. OsteoArthritis and Cartilage. 2003, 11, 738.
(5) Oelke, A. J.; France, D. J.; Hofmann, T.; Wuitschik, G.; Ley, S. V.
Angew. Chem., Int. Ed. 2010, 49, 6139.
(6) Hale, K. J.; Jogiya, N.; Manaviazar, S. Tetrahedron Lett. 1998, 39,
7163.
Scheme 2. Synthesis of the Pralnacasan Bicyclic Core
(7) (a) Kamenecka, T. M.; Danishefsky, S. J. Angew. Chem., Int. Ed.
1998, 37, 2995. (b) Boger, D. L.; Ledeboer, M. W.; Kume, M.; Searcey,
M.; Jin, Q. J. Am. Chem. Soc. 1999, 121, 11375. (c) Valognes, D.;
Belmont, P.; Xi, N.; Ciufolini, M. A. Tetrahedron Lett. 2001, 42, 1907.
(8) Paquette, L. A.; Duan, M.; Konetzki, I.; Kempmann, C. J. Am.
Chem. Soc. 2002, 124, 4257.
(9) (a) Ciufolini, M. A.; Xi, N. Chem. Soc. Rev. 1998, 27, 437.
(b) Kuchenthal, C. H.; Maison, W. Synthesis 2010, 5, 719.
(10) Aspinall, I. H.; Cowley, P. M.; Mitchell, G.; Stoodley, R. J. J. Chem.
Soc., Chem. Commun. 1993, 15, 1179.
(11) (a) Schmidt, U.; Riedl, B. J. Chem. Soc., Chem. Commun. 1992,
1186. (b) Hassall, C. H.; Johnson, W. H.; Theobald, C. J. J. Chem. Soc.,
Perkin Trans. 1 1979, 1451.
(12) Ciufolini, M. A.; Shimizu, T.; Swaminathan, S.; Xi, N. Tetrahedron
Lett. 1997, 38, 4947.
protecting group via a tandem oxidation/reduction sequence and
unmasking of its glutamic acid side chain by saponification, we
used thionyl chloride to promote the desired ring closure as
described in the patent literature.22
In summary, we have developed a novel IMCR that can be
used to efficiently prepare peptides with a N2-acyl piperazic acid
residue or its oxidized congener in only two steps. We have
shown the IMCR can tolerate a variety of carboxylic acid and
isocyanide substrates, including those that can be used for the
direct formation of peptides with tandem piperazic acid
constituents. Although the reaction is not stereoselective, we
found that the diastereomeric products can be separated easily.
This work is a practical and conceptual advance in peptide
synthesis because it capitalizes on induced intramolecularity to
circumvent challenges associated with the peculiar reactivities of
piperazic and dehydropiperazic acids. Application of the
methodology in the syntheses of natural products containing
piperazic acids will be reported in due course.
(13) (a) Boger, D. L.; Ledeboer, M. W.; Kume, M.; Jin, Q. Angew.
Chem., Int. Ed. 1999, 38, 2426. (b) Ciufolini, M. A.; Valognes, D.; Xi.
Angew. Chem., Int. Ed. 2000, 39, 2493.
(14) (a) Pascal, R. Eur. J. Org. Chem. 2003, 10, 1813. (b) . Diedrich, F.;
Stang, P. J. Templated Organic Synthesis; Wiley-VCH: Weinheim, 2000;
pp 1. (c) Gauthier, D. R.; Zandi, K. S.; Shea, K. J. Tetrahedron 1998, 54,
2289.
(15) Nutt, R. F.; Joullie,
́
M. M. J. Am. Chem. Soc. 1982, 104, 5852.
(16) (a) Domling, A.; Ugi, I. Angew. Chem., Int. Ed. 2000, 39, 3168.
̈
(b) Domling, A. Chem. Rev. 2006, 106, 17.
̈
(17) Okandeji, B. O.; Gordon, J. R.; Sello, J. K. J. Org. Chem. 2008, 73,
5595.
(18) Lin, Q.; Blackwell, H. E. Chem. Commun. 2006, 2884.
(19) Verardo, G.; Toniutti, N.; Giumanini, A. G. Tetrahedron 1997, 53,
3707.
(20) Krasavin, M.; Bushkova, E.; Parchinsky, V.; Shumsky, A. Synthesis
2010, 6, 933.
(21) Buul, S. D.; Davies, S. G.; Fenton, G.; Mulvaney, A. W.; Prasad, R.
S.; Smith, A. D. J. Chem. Soc., Perkin Trans. 1 2000, 2765.
(22) Robidoux, A. L. C.; Wilson, J. D.; Dieterich, P.; Storer, N.;
Leonardi, S. U.S. Patent 6703500; Mar 9, 2004.
ASSOCIATED CONTENT
* Supporting Information
Procedures and spectroscopic data for all compounds. This
material is available free of charge via the Internet at http://pubs.
■
S
AUTHOR INFORMATION
Corresponding Author
■
Notes
The authors declare no competing financial interest.
ACKNOWLEDGMENTS
■
J.K.S. is the recipient of a NSF CAREER Award. E.L.H. was
supported by the NSF Graduate Fellowship Program. C.P.L. was
supported by an Undergraduate Teaching and Research
Assistantship Award from Brown University. We are grateful to
T. Shen and R. Hopson at Brown for expert assistance in MS and
NMR analyses, respectively.
3491
dx.doi.org/10.1021/ol501425b | Org. Lett. 2014, 16, 3488−3491